Temozolomide treatment can improve overall survival in aggressive pituitary tumors and pituitary carcinomasHélène Lasolle, Gérald Raverot, Christine Cortet et al.|European Journal of Endocrinology|2017Cited by 142
Hepatic safety of ketoconazole in Cushing’s syndrome: results of a Compassionate Use Programme in FranceJacques Young, V. Degros, Gwénaëlle Arnault et al.|European Journal of Endocrinology|2018Cited by 70
Consensus statement by the French Society of Endocrinology (SFE) and French Society of Pediatric Endocrinology & Diabetology (SFEDP) on diagnosis of Cushing's syndromeAntoine Tabarin, Jérôme Bertherat, Guillaume Assié et al.|Annales d Endocrinologie|2022Cited by 62
Real-life efficacy and predictors of response to immunotherapy in pituitary tumors: a cohort studyMirela Diana Ilie, Gérald Raverot, Chiara Villa et al.|European Journal of Endocrinology|2022Cited by 52
Prevalence and clinical correlations of <i>SF3B1</i> variants in lactotroph tumoursJulia Simon, Marily Theodoropoulou, Luis Gustavo Perez‐Rivas et al.|European Journal of Endocrinology|2023Cited by 33